Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Suramin: here to stay!?

H I Scher

    Journal of the National Cancer Institute
    |April 21, 1993
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer.

    European journal of cancer (Oxford, England : 1990)·2021
    Same author

    Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts.

    Annals of oncology : official journal of the European Society for Medical Oncology·2018
    Same author

    Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Periprostatic adipose inflammation is associated with high-grade prostate cancer.

    Prostate cancer and prostatic diseases·2017
    Same author

    Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.

    Clinical pharmacology and therapeutics·2017